Clinical Trial Update: Monoamine Contributions to Neurocircuitry in Eating Disorders [Phase 4]

View source ↗

Summary

Phase 4 clinical trial examining monoamine contributions to neurocircuitry in eating disorders has been completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eating Disorders

Snippet

Sponsor: University of California, San Diego | Conditions: Eating Disorder | Phase 4 | Status: COMPLETED | Results posted: 2020-04-27